Department of Computational Medicine and Neuropsychiatry, Faculty of Medicine, University of Mons, Avenue du Champs de Mars 6, 7000 Mons, Belgium.
Psychiatr Danub. 2024 Sep;36(Suppl 2):348-353.
Artificial intelligence (AI) offers new perspectives in the healthcare sector, ranging from clinical decision support tools to new treatment strategies or alternative patient remote monitoring. However, as a disruptive technology, AI is associated with potential barriers, limitations and challenges for appropriate integration in medical practice. To avoid potential patient safety risks and harm, a robust regulatory framework is crucial to guide health professionals in their AI adoption in clinical practice. The European Union offers a new legal framework for the development and deployment of AI systems, the AI Act. This regulation was approved in March 2024 and will be fully applicable by 2025 to ensure that AI technologies are safe, transparent, and respect fundamental rights. However, these new regulatory concepts may be obscure for clinicians. This article aims to provide health professionals with the preliminary key points of regulation needed to interact adequately with these new AI applications and consider the potential risks of AI systems to patient safety.
人工智能(AI)在医疗保健领域提供了新的视角,包括临床决策支持工具、新的治疗策略或替代患者远程监测等。然而,作为一种颠覆性技术,AI 在适当整合到医疗实践中时,存在潜在的障碍、限制和挑战。为了避免潜在的患者安全风险和危害,健全的监管框架对于指导卫生专业人员在临床实践中采用 AI 至关重要。欧盟为 AI 系统的开发和部署提供了一个新的法律框架,即 AI 法案。该法规于 2024 年 3 月获得批准,并将于 2025 年全面适用,以确保 AI 技术安全、透明,并尊重基本权利。然而,这些新的监管概念可能对临床医生来说比较模糊。本文旨在为卫生专业人员提供与这些新的 AI 应用程序进行充分交互所需的监管要点,同时考虑 AI 系统对患者安全的潜在风险。